Precigen(PGEN)
$4.27-0.02 (-0.47%)
PGEN
Precigen financials statements
$4.27
At close:-0.02 (-0.47%)
Want to see PGEN full AI Analyst Report?
Precigen (PGEN) Ratios
1,273 Followers
Precigen Ratios
PGEN's free cash flow for Q3 2026 was $11.45M. For the 2026 fiscal year, PGEN's free cash flow was decreased by $-435.00K and operating cash flow was $11.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.09 | 4.76 | 2.99 | 1.50 | 4.52 |
| Quick Ratio | 2.83 | 4.76 | 2.99 | 1.50 | 4.51 |
| Cash Ratio | 0.81 | 1.37 | 0.33 | 0.06 | 1.05 |
| Solvency Ratio | -1.84 | -1.14 | -2.74 | 0.44 | -0.31 |
| Operating Cash Flow Ratio | -2.35 | -3.17 | -2.91 | -0.83 | -1.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -1.51 | -1072.52 |
| Net Current Asset Value | $ -19.36M | $ -4.34M | $ 36.21M | $ 28.44M | $ -95.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.63 | 0.04 | 0.05 | 0.24 | 0.53 |
| Debt-to-Equity Ratio | 4.70 | 0.14 | 0.06 | 0.41 | 1.77 |
| Debt-to-Capital Ratio | 0.82 | 0.13 | 0.06 | 0.29 | 0.64 |
| Long-Term Debt-to-Capital Ratio | 0.82 | 0.00 | 0.00 | 0.00 | 0.63 |
| Financial Leverage Ratio | 7.44 | 3.77 | 1.27 | 1.71 | 3.35 |
| Debt Service Coverage Ratio | -62.99 | -20283.83 | -189.68 | -1.24 | -4.12 |
| Interest Coverage Ratio | -27.57 | -22504.83 | -213.16 | -11.18 | -4.90 |
| Debt to Market Cap | 0.07 | 0.00 | 0.00 | 0.14 | 0.25 |
| Interest Debt Per Share | 0.34 | 0.02 | 0.03 | 0.29 | 1.06 |
| Net Debt to EBITDA | -0.28 | 0.19 | 0.01 | -0.75 | -1.98 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.05% | -8.71% | 1.70% | 76.44% | -276.24% |
| EBIT Margin | -2548.24% | -3261.71% | -1540.47% | -272.00% | -640.67% |
| EBITDA Margin | -2515.21% | -3146.39% | -1433.35% | -231.99% | -544.22% |
| Operating Profit Margin | -1100.78% | -3440.23% | -1602.54% | -281.42% | -644.48% |
| Pretax Profit Margin | -2588.18% | -3261.86% | -1547.98% | -297.17% | -777.79% |
| Net Profit Margin | -2588.21% | -3216.18% | -1540.63% | 105.23% | -646.01% |
| Continuous Operations Profit Margin | -2588.21% | -3216.18% | -1540.63% | -296.47% | -776.67% |
| Net Income Per EBT | 100.00% | 98.60% | 99.52% | -35.41% | 83.06% |
| EBT Per EBIT | 235.12% | 94.82% | 96.60% | 105.60% | 120.68% |
| Return on Assets (ROA) | -161.18% | -86.90% | -63.49% | 13.11% | -25.61% |
| Return on Equity (ROE) | -1198.61% | -327.77% | -80.93% | 22.43% | -85.86% |
| Return on Capital Employed (ROCE) | -90.19% | -109.12% | -77.90% | -55.14% | -28.27% |
| Return on Invested Capital (ROIC) | -89.33% | -106.76% | -76.81% | -41.56% | -28.11% |
| Return on Tangible Assets | -182.83% | -103.75% | -114.54% | 21.04% | -34.13% |
| Earnings Yield | -19.68% | -42.10% | -29.27% | 9.30% | -12.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.22 | 3.37 | 3.95 | 1.95 | 7.21 |
| Payables Turnover | 0.51 | 1.21 | 3.55 | 1.56 | 17.25 |
| Inventory Turnover | 0.64 | 0.00 | 0.00 | 22.09 | 164.66 |
| Fixed Asset Turnover | 0.53 | 0.21 | 0.44 | 1.76 | 0.77 |
| Asset Turnover | 0.06 | 0.03 | 0.04 | 0.12 | 0.04 |
| Working Capital Turnover Ratio | 0.12 | 0.06 | 0.15 | 0.33 | 0.12 |
| Cash Conversion Cycle | 20.47 | -193.89 | -10.61 | -30.47 | 31.71 |
| Days of Sales Outstanding | 164.41 | 108.15 | 92.35 | 187.24 | 50.66 |
| Days of Inventory Outstanding | 573.67 | 0.00 | 0.00 | 16.53 | 2.22 |
| Days of Payables Outstanding | 717.61 | 302.04 | 102.96 | 234.24 | 21.16 |
| Operating Cycle | 738.07 | 108.15 | 92.35 | 203.77 | 52.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.29 | -0.25 | -0.27 | -0.32 | -0.28 |
| Free Cash Flow Per Share | -0.29 | -0.29 | -0.28 | -0.35 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | -44.03 | -7.94 | -43.57 | -13.21 | -7.70 |
| Capital Expenditure Coverage Ratio | -44.03 | -7.94 | -43.57 | -13.21 | -7.70 |
| Operating Cash Flow Coverage Ratio | -0.89 | -12.39 | -9.43 | -1.26 | -0.29 |
| Operating Cash Flow to Sales Ratio | -9.07 | -17.37 | -10.75 | -2.42 | -3.91 |
| Free Cash Flow Yield | -7.05% | -25.60% | -20.89% | -22.97% | -8.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.96 | -2.38 | -3.42 | 10.75 | -7.96 |
| Price-to-Sales (P/S) Ratio | 131.52 | 76.40 | 52.64 | 11.32 | 51.43 |
| Price-to-Book (P/B) Ratio | 60.91 | 7.79 | 2.77 | 2.41 | 6.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.18 | -3.91 | -4.79 | -4.35 | -11.64 |
| Price-to-Operating Cash Flow Ratio | -14.50 | -4.40 | -4.90 | -4.68 | -13.16 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | -0.12 | -0.19 | -0.36 | 0.15 |
| Enterprise Value Multiple | -5.51 | -2.23 | -3.67 | -5.62 | -11.43 |
| Enterprise Value | 1.34B | 275.84M | 327.20M | 351.11M | 887.34M |
| EV to EBITDA | -5.51 | -2.23 | -3.67 | -5.62 | -11.43 |
| EV to Sales | 138.55 | 70.28 | 52.56 | 13.05 | 62.20 |
| EV to Free Cash Flow | -14.94 | -3.59 | -4.78 | -5.02 | -14.08 |
| EV to Operating Cash Flow | -15.28 | -4.05 | -4.89 | -5.40 | -15.91 |
| Tangible Book Value Per Share | 0.01 | 0.06 | 0.21 | 0.22 | 0.09 |
| Shareholders’ Equity Per Share | 0.07 | 0.14 | 0.48 | 0.63 | 0.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.03 | 0.01 | 0.03 | 0.13 | 0.07 |
| Net Income Per Share | -0.82 | -0.47 | -0.39 | 0.14 | -0.47 |
| Tax Burden | 1.00 | 0.99 | 1.00 | -0.35 | 0.83 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.09 | 1.21 |
| Research & Development to Revenue | 4.14 | 13.52 | 7.81 | 1.75 | 3.36 |
| SG&A to Revenue | 7.24 | 10.52 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.12 | 2.41 | 1.59 | 0.38 | 0.97 |
| Income Quality | 0.35 | 0.54 | 0.70 | -2.30 | 0.61 |
Currency in USD

